King-Devick Technologies, Inc.

King-Devick Technologies develops eye-movement assessment and monitoring tools for clinical, sideline, and educational applications. The company's flagship product, the King-Devick Test, is a rapid oculomotor (eye movement) screening tool designed to detect impaired saccadic function and is widely used for concussion assessment on sports sidelines. The test has been featured on major media outlets (Dr. Oz, Today Show) and recognized by Mayo Clinic as one of the top 10 most innovative contributions to healthcare. Beyond concussion management, King-Devick offers a suite of evidence-based diagnostic and monitoring solutions for oculomotor disorders, including saccadic dysfunction and age-related macular degeneration (AMD). The company also markets the King-Devick Reading Acceleration Program (K-D RAP), an eye-movement training intervention for elementary students to improve oral reading fluency and comprehension. Products are available in sideline, clinical in-office, at-home, and mobile app formats. King-Devick has received recognition from the VA Innovation Awards and the DPHARM Idol Disrupt 2020 competition. The company serves sports medicine professionals, healthcare systems, educational institutions, and government agencies including the U.S. Department of Veterans Affairs. Clinical evidence supporting the King-Devick Test has been published in peer-reviewed journals including BMJ Ophthalmology.